R Lecumberri
Overview
Explore the profile of R Lecumberri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Azorin D, Lazaro E, Ezpeleta D, Lecumberri R, de la Camara R, Castellanos M, et al.
Neurologia (Engl Ed)
. 2024 Nov;
39(9):721-732.
PMID: 39488251
Background: We describe the epidemiological and clinical characteristics of thrombosis with thrombocytopenia syndrome (TTS) cases reported in Spain. Methods: We included all cases of venous or arterial thrombosis with thrombocytopenia...
2.
Falanga A, Ay C, Di Nisio M, Gerotziafas G, Jara-Palomares L, Langer F, et al.
Ann Oncol
. 2023 Jan;
34(5):452-467.
PMID: 36638869
No abstract available.
3.
Gonzalez-Porras J, Mateo J, Gonzalez-Calle V, Marco P, Garcia-Gutierrez V, Reverter J, et al.
Clin Transl Oncol
. 2021 Dec;
24(5):770-783.
PMID: 34850351
Venous thromboembolism (VTE) is a serious complication in hematologic neoplasms, so finding adequate prevention strategies is an urgent requirement. However, prospective studies with large enough cohorts are scarce, limiting the...
4.
Paramo J, Marcos-Jubilar M, Lecumberri R
Rev Clin Esp (Barc)
. 2021 Sep;
222(2):93-99.
PMID: 34548256
Patients with cancer present with an elevated risk of thrombosis, which entails high morbidity and mortality. Various predictive scales that incorporate clinical and biological data have been developed to identify...
5.
Jara-Palomares L, van Es N, Praena-Fernandez J, Le Gal G, Otten H, Robin P, et al.
Thromb Res
. 2019 Feb;
176:79-84.
PMID: 30780008
Background: Unprovoked venous thromboembolism (VTE) may be the first manifestation of an underlying cancer. We aimed to assess the period prevalence of occult cancer detection stratified by VTE location (deep...
6.
Figueroa R, Alfonso A, Lopez-Picazo J, Gil-Bazo I, Garcia-Mouriz A, Hermida J, et al.
Clin Transl Oncol
. 2018 Nov;
21(6):805-809.
PMID: 30446983
Purpose: Thromboprophylaxis use among medical inpatients, including cancer patients, is suboptimal. We aimed to evaluate the impact of a novel multiscreen version (v2.0) of an e-alert system for VTE prevention...
7.
Delluc A, Antic D, Lecumberri R, Ay C, Meyer G, Carrier M
J Thromb Haemost
. 2017 Aug;
15(10):2076-2079.
PMID: 28851126
No abstract available.
8.
Jimenez-Fonseca P, Carmona-Bayonas A, Calderon C, Fontcuberta Boj J, Font C, Lecumberri R, et al.
Clin Transl Oncol
. 2017 Mar;
19(8):997-1009.
PMID: 28243988
Introduction: Decision-making in cancer-related venous thromboembolism (VTE) is often founded on scant lines of evidence and weak recommendations. The aim of this work is to evaluate the percentage of agreement...
9.
Martinez-Calle N, Hidalgo F, Alfonso A, Munoz M, Hernandez M, Lecumberri R, et al.
Med Intensiva
. 2016 Jul;
40(9):550-559.
PMID: 27425576
Objective: To audit the impact upon mortality of a massive bleeding management protocol (MBP) implemented in our center since 2007. Design: A retrospective, single-center study was carried out. Patients transfused...
10.
Schulman S, Zondag M, Linkins L, Pasca S, Cheung Y, de Sancho M, et al.
J Thromb Haemost
. 2015 Apr;
13(6):1010-8.
PMID: 25851122
Background: Recommendations for management of cancer-related venous thromboembolism (VTE) in patients already receiving anticoagulant therapy are based on low-quality evidence. This international registry sought to provide more information on outcomes...